Klaire Labs, established in 1969 by Claire Farr, has built a legacy on the foundation of delivering pharmaceutical-grade formulations to the nutritional supplement market. With an unwavering commitment to purity, potency, and performance, Klaire Labs became the standard-bearer in the industry, initially attracting the medical community's attention with its clean, potent, and effective supplements.

Claire Farr set the bar high from the outset by opting for pharmaceutical-grade raw ingredients, selected for their supreme purity and bioavailability. She shunned the use of fillers and synthetic additives, focusing instead on natural and synergistic components that ensure maximum health benefits.

After being acquired by ProThera, Inc. in 2004, and later becoming part of the Soho Flordis International (SFI) family in 2013, Klaire Labs has continued to innovate while staying true to its foundational values. Under SFI, the brand has flourished, bringing together sister brands and streamlining operations to maintain its reputation for quality and efficacy.

The state-of-the-art cGMP manufacturing plant in Reno, established by SFI, represents a significant investment in continuing the legacy of Claire Farr. This facility ensures that each product not only meets but exceeds rigorous quality standards.

Today, Klaire Labs is recognized for its strong reputation among discerning healthcare practitioners. It leads the way in fields such as Microbiome and GI Health, boasting the top professionally distributed probiotic line in the United States, Ther-Biotic®.

As part of the SFI family, Klaire Labs benefits from over 200 years of combined history in natural health and wellness. SFI’s commitment to extensive research, rigorous processes, and quality ingredient sourcing ensures that Klaire Labs continues to offer solutions that are not only effective but also trustworthy and reliable.